Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Prasad Dandawate"'
Autor:
David Standing, Prasad Dandawate, Sumedha Gunewardena, Obdulia Covarrubias-Zambrano, Katherine F. Roby, Dineo Khabele, Andrea Jewell, Ossama Tawfik, Stefan H. Bossmann, Andrew K. Godwin, Scott J. Weir, Roy A. Jensen, Shrikant Anant
Publikováno v:
Cell Death and Disease, Vol 15, Iss 5, Pp 1-16 (2024)
Abstract Advanced epithelial ovarian cancer (EOC) survival rates are dishearteningly low, with ~25% surviving beyond 5 years. Evidence suggests that cancer stem cells contribute to acquired chemoresistance and tumor recurrence. Here, we show that IRA
Externí odkaz:
https://doaj.org/article/a34cd1f4ae354f69b2bfaed9395015fa
Autor:
Jingyi Ma, Dileepkumar Veeragoni, Hindole Ghosh, Nicole Mutter, Gisele Barbosa, Lauren Webster, Rainer Schobert, Wendy van de Sande, Prasad Dandawate, Bernhard Biersack
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1621 (2024)
The approved anthelmintic salicylanilide drug niclosamide has shown promising anticancer and antimicrobial activities. In this study, new niclosamide derivatives with trifluoromethyl, trifluoromethylsulfanyl, and pentafluorosulfanyl substituents repl
Externí odkaz:
https://doaj.org/article/b6f46fec24a64e0baa61fbfd34ba94b5
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2023)
Prolactin (PRL) is a peptide hormone mainly secreted from the anterior pituitary gland. PRL is reported to play a role in pregnancy, mammary gland development, immune modulation, reproduction, and differentiation of islet cells. PRL binds to its rece
Externí odkaz:
https://doaj.org/article/39314eb1c15c4fbe89a35ef0af1b9202
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1921 (2023)
Pancreatic carcinoma is a cancer disease with high mortality. Thus, new and efficient treatments for this disease are badly needed. Curcumin has previously shown promising effects in pancreatic cancer patients; however, this natural compound suffers
Externí odkaz:
https://doaj.org/article/6496dab7061a48e29fee709ff8caf30f
Autor:
Sangita Bhattacharyya, Hindole Ghosh, Obdulia Covarrubias-Zambrano, Krishan Jain, K. Venkateswara Swamy, Anup Kasi, Ameer Hamza, Shrikant Anant, Michael VanSaun, Scott J. Weir, Stefan H. Bossmann, Subhash B. Padhye, Prasad Dandawate
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6336 (2023)
Pancreatic ductal adenocarcinoma (PDAC) is the primary reason for cancer-related deaths in the US. Genetic mutations, drug resistance, the involvement of multiple signaling pathways, cancer stem cells (CSCs), and desmoplastic stroma, which hinders dr
Externí odkaz:
https://doaj.org/article/bcd519e0deb046baaf12a90c86b0da00
Autor:
Sebastian W. Schleser, Hindole Ghosh, Gerald Hörner, Jonathan Seib, Sangita Bhattacharyya, Birgit Weber, Rainer Schobert, Prasad Dandawate, Bernhard Biersack
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5738 (2023)
Inspired by the vascular-disrupting agent combretastatin A-4 and recently published anticancer active N-heterocyclic carbene (NHC) complexes of Au(I), a series of new iodidogold(I)–NHC complexes was synthesized and characterized. The iodidogold(I)
Externí odkaz:
https://doaj.org/article/5a8e968b56ea44be89ea6464d3add8da
Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex
Autor:
Scott J. Weir, Prasad Dandawate, David Standing, Sangita Bhattacharyya, Prabhu Ramamoorthy, Parthasarathy Rangarajan, Robyn Wood, Amanda E. Brinker, Benjamin L. Woolbright, Mehmet Tanol, Tammy Ham, William McCulloch, Michael Dalton, Gregory A. Reed, Michael J. Baltezor, Roy A. Jensen, John A. Taylor, Shrikant Anant
Publikováno v:
Cell Death and Disease, Vol 12, Iss 6, Pp 1-20 (2021)
Abstract Ciclopirox (CPX) is an FDA-approved topical antifungal agent that has demonstrated preclinical anticancer activity in a number of solid and hematologic malignancies. Its clinical utility as an oral anticancer agent, however, is limited by po
Externí odkaz:
https://doaj.org/article/d4bbf6c8245447f1b012189797bdb6c4
Autor:
Natalie Oberhuber, Hindole Ghosh, Bianca Nitzsche, Prasad Dandawate, Michael Höpfner, Rainer Schobert, Bernhard Biersack
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 854 (2023)
New N-alkylindole-substituted 2-(pyrid-3-yl)-acrylonitriles with putative kinase inhibitory activity and their (p-cymene)Ru(II) piano-stool complexes were prepared and tested for their antiproliferative efficacy in various cancer models. Some of the
Externí odkaz:
https://doaj.org/article/390ce5e887f045628df33ba641574a8a
Autor:
Dharmalingam Subramaniam, Pablo Angulo, Sivapriya Ponnurangam, Prasad Dandawate, Prabhu Ramamoorthy, Pugazhendhi Srinivasan, Tomoo Iwakuma, Scott J. Weir, Katherine Chastain, Shrikant Anant
Publikováno v:
Cell Death and Disease, Vol 11, Iss 2, Pp 1-15 (2020)
Abstract Osteosarcoma (OS) is the most common primary bone tumor that primarily affects children and adolescents. Studies suggested that dysregulation JAK/STAT signaling promotes the development of OS. Cells treated with pimozide, a STAT5 inhibitor s
Externí odkaz:
https://doaj.org/article/5d310a6efbe6464b9de53da6369710ad
Autor:
Taylor E. Escher, Prasad Dandawate, Afreen Sayed, Christy R. Hagan, Shrikant Anant, Joan Lewis-Wambi
Publikováno v:
Cancers, Vol 13, Iss 20, p 5130 (2021)
Aromatase inhibitors (AIs) reduce estrogen levels up to 98% as the standard practice to treat postmenopausal women with estrogen receptor-positive (ER+) breast cancer. However, approximately 30% of ER+ breast cancers develop resistance to treatment.
Externí odkaz:
https://doaj.org/article/40540b3bea6444339b225a7762162b7e